Transforming cancer treatment by enhancing immunotherapy
We develop innovative cancer therapies to induce tumor necrosis and enhance antitumor immunity, offering cancer patients the hope of longer, better lives.
![Key Visual](/_next/image?url=%2Fimages%2Fhome%2Fhome_key_visual.png&w=3840&q=75&dpl=dpl_3KxN4oVkPje7fMUSYkGf6hrTDnFp)
![Our Approach](/_next/image?url=%2Fimages%2Fhome%2Fhome_our_approach.png&w=3840&q=75&dpl=dpl_3KxN4oVkPje7fMUSYkGf6hrTDnFp)
Our Pipeline
Our innovative approaches aim to enhance immune checkpoint inhibitors (ICIs) and prolong the lives of patients with solid tumor cancers that have metastasized to the liver.
"We believe in our pipeline's ability to enhance and achieve long-term remission for patients"
![Our Pipeline](/_next/image?url=%2Fimages%2Fhome%2Fhome_our_pipeline.png&w=3840&q=75&dpl=dpl_3KxN4oVkPje7fMUSYkGf6hrTDnFp)
![Careers and Contact Us](/_next/image?url=%2Fimages%2Fhome%2Fhome_career_contact_us.png&w=3840&q=75&dpl=dpl_3KxN4oVkPje7fMUSYkGf6hrTDnFp)